FDA Chides Sunovion Over Misstating Brovana Risks, Benefits
Sunovion Pharmaceuticals Inc. promoted its respiratory drug Brovana in a deceptive manner that buried discussion of risks in fine print and exaggerated effectiveness by suggesting the product would completely revitalize patients,...To view the full article, register now.
Already a subscriber? Click here to view full article